Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Credit Suisse Downgrades New Frontier Health to Neutral, Announces $12 Price Target

Author: Benzinga Newsdesk | April 09, 2021 07:12am
Credit Suisse analyst Jason Liu downgrades New Frontier Health (NYSE:NFH) from Outperform to Neutral and announces $12 price target.

Posted In: NFH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist